Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Akalu Banbeta Tereda, Legesse Kassa Debusho
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
10.1080/19466315.2023.2190933
10.1080/19466315.2023.2190933
10.1002/pst.2178
10.1002/pst.2178
10.1002/sim.8019
10.1002/sim.8019
On the foundations of statistical inference
10.1080/01621459.1962.10480660 · 1996
10.1080/10618600.1998.10474787
10.1080/10618600.1998.10474787
10.1002/env.752
10.1002/env.752
Marginal likelihood estimation via power posteriors
10.1111/j.1467-9868.2007.00650.x · 2008
10.1214/ss/1028905934
10.1214/ss/1028905934
10.1080/01621459.1993.10476353
10.1080/01621459.1993.10476353
10.1093/oso/9780198522669.003.0010
10.1093/oso/9780198522669.003.0010
10.1002/bimj.201700246
10.1002/bimj.201700246
10.1002/sim.5851
10.1002/sim.5851
A phase iii, randomized, double-blind, parallel-group, placebo-conrolled, multicentre study to assess the efficacy and safety of the adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder
10.1016/j.urology.2013.02.077 · 2013
10.1111/j.1541-0420.2011.01564.x
10.1111/j.1541-0420.2011.01564.x
10.1214/12-ba722
10.1214/12-ba722
10.1214/ss/1009212673
10.1214/ss/1009212673
10.1002/sim.6728
10.1002/sim.6728
Efficacy and tolerability of mirabegron, a beta(3)- adrenoceptor agonist, in patients with overactive bladder: results from a randomized european-australian phase 3 trial
10.1016/j.eururo.2012.10.016 · 2013
A review of dynamic borrowing methods with applications in pharmaceutical research Brazilian journal of probability and statistics
2024
10.1002/sim.782
10.1002/sim.782
10.1002/pst.1664
10.1002/pst.1664
10.1002/pst.1722
10.1002/pst.1722
10.1177/1740774509356002
10.1177/1740774509356002
10.1016/j.juro.2012.10.017
10.1016/j.juro.2012.10.017
10.1016/0021-9681(76)90044-8
10.1016/0021-9681(76)90044-8
10.1111/biom.12242
10.1111/biom.12242
Including historical data in the analysis of clinical trials: Is it worth the effort?
10.1177/0962280217694506 · 2018
No additional external references are available.